Inflammatory bowel disease events after exposure to the interleukin-17 inhibitors ixekizumab and secukinumab: A report from the RADAR (Research on Adverse Drug Events and Reports) project

2018 ◽  
Vol 79 (3) ◽  
pp. AB168
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Adverse Drug Events ◽  
Interleukin 17 ◽  
Inflammatory Bowel

scholarly journals The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease

2010 ◽  
Vol 160 (3) ◽  
pp. 386-393 ◽  
Author(s):  
T. Sugihara ◽  
A. Kobori ◽  
H. Imaeda ◽  
T. Tsujikawa ◽  
K. Amagase ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Complement C3 ◽  
Interleukin 17 ◽  
Inflammatory Bowel

scholarly journals Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233781 ◽  
Author(s):  
Johan Burisch ◽  
Wolfgang Eigner ◽  
Stefan Schreiber ◽  
Daniel Aletaha ◽  
Wolfgang Weninger ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Meta Analysis ◽  
Interleukin 17 ◽  
Inflammatory Bowel

After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

2007 ◽  
Vol 7 (4) ◽  
pp. 409-416 ◽  
Author(s):  
Zili Zhang ◽  
David J. Hinrichs ◽  
Huiying Lu ◽  
Hong Chen ◽  
Wenwei Zhong ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Therapeutic Targets ◽  
Interleukin 17 ◽  
Inflammatory Bowel ◽  
Interleukin 23

scholarly journals Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

2020 ◽  
Vol 9 ◽  
pp. 1-9 ◽  
Author(s):  
Keira A Fieldhouse ◽  
Samantha Ukaibe ◽  
Erika L Crowley ◽  
Reena Khanna ◽  
Ashley O’Toole ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Interleukin 17 ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document